The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.
Saved in:
| Title: | The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C. |
|---|---|
| Authors: | Shi Y; Merck & Co., Inc., Rahway, NJ, USA., Nolan KM; Merck & Co., Inc., Rahway, NJ, USA., Burton RL; SunFire Biotechnologies LLC, Birmingham, AL, USA., Shekar T; Merck & Co., Inc., Rahway, NJ, USA., Murphy RD; Merck & Co., Inc., Rahway, NJ, USA., Banniettis N; Merck & Co., Inc., Rahway, NJ, USA., Musey L; Merck & Co., Inc., Rahway, NJ, USA., Buchwald UK; Merck & Co., Inc., Rahway, NJ, USA. |
| Source: | Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Aug 01; Vol. 19 (2), pp. 2235238. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
